Navigation Links
Drop in Breast Cancer Rates Due to Drop in HRT Use
Date:2/4/2009

Researchers say first two years of combined hormone therapy a 'safe' period

WEDNESDAY, Feb. 4 (HealthDay News) -- A new analysis shows that the drop in breast cancer cases that began in 2003 is indeed due to women stopping hormone replacement therapy (HRT) after a large, U.S. study showed surprisingly higher rates of heart problems and breast cancer among users of some kinds of HRT.

Some experts have suggested such a theory explains the trend, while others have said it might be related to changes in mammography use.

"If you stop hormones, the risk of breast cancer [associated with hormone use] rapidly declines," said Dr. Rowan Chlebowski, a medical oncologist at Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center and lead author of the analysis in the Feb. 5 issue of the New England Journal of Medicine.

Based on that analysis and another recent review, the researchers also suggested that the "safe" period for combined use of progestin and estrogen to relieve postmenopausal symptoms was probably about two years, not the approximately five years researchers have discussed previously.

To get to the root of the drop in breast cancer cases, Chlebowski and his colleagues looked at data from the Women's Health Initiative (WHI) clinical trial (more than 15,000 women were assigned to either a placebo or HRT) and an observational study in which more than 25,000 women were on HRT, and more than 16,000 were not.

The part of the WHI that looked at combined hormone therapy was halted in 2002, as soon as researchers saw surprisingly higher rates of heart problems and breast cancer in women assigned to take the combined HRT (but not estrogen alone).

When Chlebowski's group looked in more detail and at shorter intervals for the effects of HRT, they found that during the initial two years, the HRT group participating in the clinical trial had fewer breast cancer diagnoses than
'/>"/>

Copyright©2009 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. U-M Study: 19% of Breast Cancer Patients Dont Receive Recommended Radiation After Mastectomy
2. 19 percent of breast cancer patients dont receive recommended radiation after mastectomy
3. 19 percent of breast cancer patients don’t receive recommended radiation after mastectomy
4. Milkscreen Home Test for Alcohol in Breast Milk Begins Nationwide Sales at Walgreens
5. NCCN Updates Breast Cancer and Breast Cancer Risk Reduction Guidelines
6. 11-gauge needle better than 14-gauge in breast biopsy
7. Workforce shortages in mammography could threaten early detection rates for breast cancer
8. Radiologists overestimate their overall risk of malpractice lawsuits in breast imaging
9. PET/CT may improve prognosis for patients with inflammatory breast cancer
10. Smithfield Foods Lean Generation(R) Deli Partnership with National Breast Cancer Foundation Celebrates $135,000 Contribution
11. Automated screening process may eventually reduce additional breast cancer surgeries
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Drop in Breast Cancer Rates Due to Drop in HRT Use
(Date:8/21/2014)... To sexually objectify a woman is to focus on ... sexual pleasure rather than viewing her as a complete ... long been considered a problem in the media, how ... in Psychology of Women Quarterly , a SAGE ... body is related to higher incidents of sexual pressure ...
(Date:8/21/2014)... London, UK (PRWEB) August 21, 2014 ... from USD 15.6 billion in 2014 and reach USD ... during the forecast period. The drivers of such growth ... products, rising obese and diabetic population, and surging ageing ... costs of state-of-the-art wound care products. Region-wise, North America ...
(Date:8/21/2014)... Revista, a one-stop source for healthcare ... is “on a roll.” Today, the Annapolis-based company ... Southeast, Mid-Atlantic and Midwest areas of the country ... available, comprehensive medical property database tracking these regions. ... including existing and recently added, is 34,549. This ...
(Date:8/21/2014)... News) -- Using two types of polio vaccines seems ... boost efforts to eradicate polio, a new study shows. ... found that giving the Salk inactivated poliovirus vaccine (IPV) ... live-attenuated oral poliovirus vaccine (OPV) appeared to improve their ... findings, reported in the Aug. 22 issue of the ...
(Date:8/21/2014)... (CHEST) announces the immediate release of Care of ... Disasters: CHEST Consensus Statement today in the Online ... while the global health-care community cares for patients ... to guide ethical decision-making, coordination of care, resource ... developed by over 100 clinicians and experts representing ...
Breaking Medicine News(10 mins):Health News:Objectification in romantic relationships related to sexual pressure and coercion 2Health News:Global Wound Care Market to Post 3.2% CAGR Through 2019, Says MarketsandMarkets in Its New Report Published at MarketPublishers.com 2Health News:Global Wound Care Market to Post 3.2% CAGR Through 2019, Says MarketsandMarkets in Its New Report Published at MarketPublishers.com 3Health News:Revista Medical Property Data Now Available for the Mid-Atlantic, Southeast and Midwest Regions 2Health News:Revista Medical Property Data Now Available for the Mid-Atlantic, Southeast and Midwest Regions 3Health News:Revista Medical Property Data Now Available for the Mid-Atlantic, Southeast and Midwest Regions 4Health News:Revista Medical Property Data Now Available for the Mid-Atlantic, Southeast and Midwest Regions 5Health News:Two Polio Vaccines May Give Greater Protection Against Crippling Disease 2Health News:CHEST releases new expert guidance in care of the critically ill and injured 2
... possible genetic cause for increased risk for a ... that leads to shorter survival, according to data ... journal of the American Association for Cancer Research. ... and differences in colorectal cancer incidence, aggressiveness and ...
... N.C. A recent discovery by researchers at Wake Forest ... new drug that inhibits tumor growth in cancer patients and ... discovery stems from a study, recently published in the ... United States of America, in which researchers looked at angiogenesis ...
... 31 Rheumatoid arthritis (RA) is a systemic disease ... system attacks the joints through the thin layer of ... joints. The most visible symptoms of RA are swollen ... feet. It can cause fatigue, fever, loss of appetite ...
... it is recalling Kroger Lite Mayo in 32-ounce plastic jars with ... Southwestern Ohio, including Cincinnati and Dayton, and in Northern Kentucky and ... illnesses have been reported in connection with the product. Kroger is ... , Kroger Lite Mayo sold ...
... As the United States prepares to reduce troop ... as 4.7 million displaced civilians in the region remain at ... strategy for addressing Iraq,s socioeconomic needs.In prepared remarks delivered Tuesday ... and South Asia, International Medical Corps President & CEO Nancy ...
... Corporation (NYSE: PRA ) announced today that the ... (PICA) have overwhelmingly approved the sponsored demutualization that will bring ... as a standalone subsidiary. The transaction, which requires final regulatory approval ... Illinois , is expected to close early in the second ...
Cached Medicine News:Health News:Blood protein may hold key to stopping tumor growth in cancer patients 2Health News:Frost & Sullivan: Rheumatoid Arthritis Therapeutics in Malaysia 2Health News:Frost & Sullivan: Rheumatoid Arthritis Therapeutics in Malaysia 3Health News:In Testimony before Senate, International Medical Corps CEO Urges U.S. to Increase Support for Displaced Iraqis 2Health News:PICA Policyholders Approve ProAssurance Transaction 2Health News:PICA Policyholders Approve ProAssurance Transaction 3Health News:PICA Policyholders Approve ProAssurance Transaction 4Health News:PICA Policyholders Approve ProAssurance Transaction 5Health News:PICA Policyholders Approve ProAssurance Transaction 6
(Date:8/21/2014)...  The board of directors of VirtualScopics, Inc. (NASDAQ: ... trial imaging solutions, today announced that James Groff ... immediately.  Mr. Groff has held the role of acting ... in January 2006 as an accounting manager and was ... the board of VirtualScopics asked Jim to assume the ...
(Date:8/21/2014)... Aug. 21, 2014  SI-BONE, Inc. ( San ... pioneered the use of the iFuse Implant System, ® ... fusion of the sacroiliac (SI) joint, announced that Priority ... to its Lumbar Fusion Medical Policy No. 91590-R4 providing ... The policy states that the fusion procedure, which employs ...
(Date:8/20/2014)... , Aug. 20, 2014  The National ... the latest results achieved by the real-time, pseudoephedrine ... the National Precursor Log Exchange (NPLEx), automatically blocks ... track down meth offenders and make arrests. Data ... Kentucky blocked the sale of ...
Breaking Medicine Technology:VirtualScopics, Inc. Names James Groff Chief Financial Officer 2VirtualScopics, Inc. Names James Groff Chief Financial Officer 3VirtualScopics, Inc. Names James Groff Chief Financial Officer 4SI-BONE, Inc. Announces Positive Coverage Decision by Priority Health 2SI-BONE, Inc. Announces Positive Coverage Decision by Priority Health 3Kentucky's Stop-Sale System Achieves Significant Results In Battle Against Meth 2
... MISSISSAUGA, Ontario, March 11, 2011 Valeant Pharmaceuticals ... VRX) announced that effective March 10, 2011, the ... S.A. About Valeant Valeant Pharmaceuticals ... pharmaceutical company that develops, manufactures and markets a ...
... (Nasdaq: OPTR ) today announced 2010 fourth quarter ... (Logo:   http://www.newscom.com/cgi-bin/prnh/20090413/LA97352LOGO ) Optimer reported a ... of $11.9 million, or $0.31 per common share, as compared ... common share, for the same period in 2009.  Optimer reported ...
Cached Medicine Technology:Optimer Pharmaceuticals Reports Fourth Quarter and Full Year 2010 Financial Results 2Optimer Pharmaceuticals Reports Fourth Quarter and Full Year 2010 Financial Results 3Optimer Pharmaceuticals Reports Fourth Quarter and Full Year 2010 Financial Results 4Optimer Pharmaceuticals Reports Fourth Quarter and Full Year 2010 Financial Results 5Optimer Pharmaceuticals Reports Fourth Quarter and Full Year 2010 Financial Results 6Optimer Pharmaceuticals Reports Fourth Quarter and Full Year 2010 Financial Results 7Optimer Pharmaceuticals Reports Fourth Quarter and Full Year 2010 Financial Results 8
DSL-10-49200 is a rapid, direct enzyme immunoassay (EIA) kit that provides materials for the quantitative measurement of testosterone in serum. This kit requires no sample extraction or pretreatment...
RIA kit for the quantitative determination of autoantibodies to steroid 21-hydroxylase (21-OH) in serum....
... volume for use with 4, 8, or 12 ... withdrawal of nearly all of the solution. Corners ... Made of natural virgin polystyrene containing no regrinds. ... by irradiation. Dimensions: 78 mm W x 152 ...
... Increased volume for use with 4, ... and V-shaped bottom permits withdrawal of nearly ... lips to dispose of excess solution. Made ... Non-sterile. Dimensions: 78 mm W x 152 ...
Medicine Products: